BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10619840)

  • 1. Structural basis of sialyltransferase activity in trypanosomal sialidases.
    Buschiazzo A; Tavares GA; Campetella O; Spinelli S; Cremona ML; París G; Amaya MF; Frasch AC; Alzari PM
    EMBO J; 2000 Jan; 19(1):16-24. PubMed ID: 10619840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sialidase mutant displaying trans-sialidase activity.
    Paris G; Ratier L; Amaya MF; Nguyen T; Alzari PM; Frasch AC
    J Mol Biol; 2005 Jan; 345(4):923-34. PubMed ID: 15588836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-sialidase-like sequences from Trypanosoma congolense conserve most of the critical active site residues found in other trans-sialidases.
    Tiralongo E; Martensen I; Grötzinger J; Tiralongo J; Schauer R
    Biol Chem; 2003 Aug; 384(8):1203-13. PubMed ID: 12974389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural studies on the Pseudomonas aeruginosa sialidase-like enzyme PA2794 suggest substrate and mechanistic variations.
    Xu G; Ryan C; Kiefel MJ; Wilson JC; Taylor GL
    J Mol Biol; 2009 Feb; 386(3):828-40. PubMed ID: 19166860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase.
    Amaya MF; Buschiazzo A; Nguyen T; Alzari PM
    J Mol Biol; 2003 Jan; 325(4):773-84. PubMed ID: 12507479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution.
    Trapani S; Linss J; Goldenberg S; Fischer H; Craievich AF; Oliva G
    J Mol Biol; 2001 Nov; 313(5):1059-72. PubMed ID: 11700062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed mutagenesis of the Trypanosoma cruzi trans-sialidase enzyme identifies two domains involved in its sialyltransferase activity.
    Smith LE; Eichinger D
    Glycobiology; 1997 Apr; 7(3):445-51. PubMed ID: 9147054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing molecular function of trypanosomal sialidases: single point mutations can change substrate specificity and increase hydrolytic activity.
    Paris G; Cremona ML; Amaya MF; Buschiazzo A; Giambiagi S; Frasch AC; Alzari PM
    Glycobiology; 2001 Apr; 11(4):305-11. PubMed ID: 11358879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing the sialidase activity of multifunctional Pasteurella multocida α2-3-sialyltransferase 1 (PmST1) by site-directed mutagenesis.
    Sugiarto G; Lau K; Li Y; Khedri Z; Yu H; Le DT; Chen X
    Mol Biosyst; 2011 Nov; 7(11):3021-7. PubMed ID: 21858283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of T. rangeli, T. brucei gambiense, and T. evansi sialidases in complex with the DANA inhibitor.
    Lima AH; Souza PR; Alencar N; Lameira J; Govender T; Kruger HG; Maguire GE; Alves CN
    Chem Biol Drug Des; 2012 Jul; 80(1):114-20. PubMed ID: 22416952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase.
    Amaya MF; Watts AG; Damager I; Wehenkel A; Nguyen T; Buschiazzo A; Paris G; Frasch AC; Withers SG; Alzari PM
    Structure; 2004 May; 12(5):775-84. PubMed ID: 15130470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma rangeli sialidase: cloning, expression and similarity to T. cruzi trans-sialidase.
    Buschiazzo A; Campetella O; Frasch AC
    Glycobiology; 1997 Dec; 7(8):1167-73. PubMed ID: 9455917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of catalytic function by differential plasticity of the active site: case study of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase.
    Demir O; Roitberg AE
    Biochemistry; 2009 Apr; 48(15):3398-406. PubMed ID: 19216574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of primary structure modifications in Trypanosoma cruzi neuraminidase/trans-sialidase activities.
    Cremona ML; Pollevick GD; Frasch AC; Campetella O
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):697-702. PubMed ID: 8832101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
    Neres J; Bryce RA; Douglas KT
    Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
    Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
    Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. trans-sialidase of Trypanosoma cruzi: location of galactose-binding site(s).
    Chuenkova M; Pereira M; Taylor G
    Biochem Biophys Res Commun; 1999 Aug; 262(2):549-56. PubMed ID: 10462512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating the regioselectivity of a Pasteurella multocida sialyltransferase for biocatalytic production of 3'- and 6'-sialyllactose.
    Guo Y; Jers C; Meyer AS; Li H; Kirpekar F; Mikkelsen JD
    Enzyme Microb Technol; 2015 Oct; 78():54-62. PubMed ID: 26215345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationalization of the difference in lifetime of two covalent sialosyl-enzyme intermediates of Trypanosoma rangeli sialidase.
    Parker LL; Chung YH; Margulis CJ; Jensen JH
    J Phys Chem B; 2008 Nov; 112(45):14093-5. PubMed ID: 18925775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.